Portola Pharmaceuticals' Series C - II Round

Portola Pharmaceuticals raised a round of funding on July 17, 2008.

Portola is a biopharmaceutical company focused on the development and commercialization of therapeutics in the areas of thrombosis, other hematologic disorders and inflammation for patients who curren…

Articles about Portola Pharmaceuticals' Series C - II Round: